慢病轨迹管理模式对38例乳腺癌患者化疗期间的研究

Study on 38 Cases of Breast Cancer during Chemotherapy with Chronic Disease Track Management Mode

摘要: 目的：对乳腺癌患者化疗期间采用慢病轨迹管理的效果进行分析。方法：选择2022年6月~2023年11月在我院诊疗的乳腺癌病患(38例)进行研究，随机分观察组、对照组，各分19例。对照组予以常规普通护理，观察组予以慢病轨迹管理，对比2组不同护理结果(自我效能、生活质量、PICC置管并发症以及骨髓抑制)。结果：观察组自我效能明显优于对照组，且差异具统计学意义，p < 0.05。观察组生活质量比对照组高，差异具有统计学的意义，p < 0.05。观察组PICC置管不良反应情况低于对照组，差异存在统计学意义，p < 0.05。对照组骨髓抑制率比观察组高，p < 0.05。结论：对乳腺癌化疗病患采取慢病轨迹管理，可改善其自我效能，提高生活质量，减少并发症，降低骨髓抑制率，效果理想，建议推崇运用。

Abstract: Objective: To analyze the effect of chronic disease track management on breast cancer patients during chemotherapy. Methods: 38 breast cancer patients (38 cases) diagnosed and treated in our hospital from June 2022 to November 2023 were randomly divided into observation group and control group, with 19 cases in each group. The control group received routine nursing care, while the observation group received chronic disease trajectory management. The different nursing outcomes (self-efficacy, quality of life, PICC catheterization complications, and bone marrow suppression) of the two groups were compared. Result: The self-efficacy of the observation group was significantly better than that of the control group, and the difference was statistically significant, p < 0.05. The quality of life of the observation group was higher than that of the control group, and the difference was statistically significant, p < 0.05. The incidence of adverse reactions to PICC catheterization in the observation group was lower than that in the control group, and the difference was statistically significant, p < 0.05. The bone marrow suppression rate in the control group was higher than that in the observation group, p < 0.05. Conclusion: The management of chronic disease track for chemotherapy patients with breast cancer can improve their self-efficacy, improve their quality of life, reduce complications, and reduce the rate of bone marrow suppression. The effect is ideal, and it is recommended to use it.